金城医药：2025年第一季度净利润3505.48万元，同比下降57.75%

Group 1 - The core point of the article indicates that Jincheng Pharmaceutical (300233) reported a revenue of 722 million yuan in the first quarter of 2025, representing a year-on-year decline of 22.52% [1] - The net profit for the same period was 35.05 million yuan, which reflects a significant year-on-year decrease of 57.75% [1]